Victrex (LON:VCT) had its price objective boosted by equities researchers at Berenberg Bank from GBX 1,320 ($18.24) to GBX 1,380 ($19.07) in a report released on Friday, February 23rd. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s price objective indicates a potential downside of 46.26% from the company’s current price.
A number of other brokerages have also commented on VCT. Barclays decreased their price objective on Victrex from GBX 2,350 ($32.47) to GBX 2,270 ($31.36) and set an “equal weight” rating for the company in a research report on Tuesday, November 28th. JPMorgan Chase & Co. raised their price objective on Victrex from GBX 2,250 ($31.09) to GBX 2,580 ($35.65) and gave the stock a “neutral” rating in a research report on Monday, January 8th. Peel Hunt raised their price objective on Victrex from GBX 2,300 ($31.78) to GBX 2,400 ($33.16) and gave the stock a “hold” rating in a research report on Tuesday, February 6th. Liberum Capital restated a “buy” rating and set a GBX 2,770 ($38.27) price objective on shares of Victrex in a research report on Wednesday, January 24th. Finally, Numis Securities restated a “hold” rating and set a GBX 2,550 ($35.23) price objective (up from GBX 2,300 ($31.78)) on shares of Victrex in a research report on Monday, February 12th. Eight analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of GBX 2,246.80 ($31.04).
Shares of Victrex (VCT) remained flat at $GBX 2,568 ($35.48) during midday trading on Friday. The stock had a trading volume of 215,604 shares, compared to its average volume of 267,048. Victrex has a 1-year low of GBX 1,826 ($25.23) and a 1-year high of GBX 2,772 ($38.30). The stock has a market capitalization of $2,210.00 and a price-to-earnings ratio of 2,213.79.
TRADEMARK VIOLATION WARNING: “Victrex (VCT) PT Raised to GBX 1,380 at Berenberg Bank” was first published by BBNS and is the property of of BBNS. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://baseballnewssource.com/2018/03/13/victrex-vct-pt-raised-to-gbx-1380-at-berenberg-bank/1922433.html.
Victrex Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.